Perpetual Medicines Raises $8M in Seed Funding

Perpetual Medicine, a Shanghai, China- and Boston, MA-based computational peptide therapeutics company, raised $8M in Seed funding.

The round was led by Chengwei Capital.

The company intends to use the funds to advance its integrated computational design and synthesis platform for peptide drug discovery.

Perpetual Medicines is a computational peptide therapeutics company that aims to build a peptide drug discovery engine. Its platform combines the predictive computational physics methods and AI technologies with synthetic chemistry to discover the peptide chemical space. The platform is designed to address previously undruggable targets, accelerate discovery and enhance the quality of peptide drug candidates.

The company also announced key appointments to its leadership team, including Kerry L. Blanchard, MD, PhD, Co-founder, CEO, Ved Srivastava, PhD, CTO, and Xiang Ye, PhD, CSO.

Perpetual Medicine, a Shanghai, China- and Boston, MA-based computational peptide therapeutics company, raised $8M in Seed funding.Best wishes to everyone in the group. This will be a huge accomplishment for them in the future.

Shishir Gupta, The Founder & CEO of StartupLanes

About us: StartupLanes is an ecosystem for Startups and Investors. Collaborate or find a co-founder, it’s a platform for Entrepreneurs. We love startups! A place for Angel Investors and Venture Capitalists to find investing opportunities in startups. Validate your idea, Learn & Execute.

Startups looking for funding may apply through StartupLanes Funding Application.

Angel Investors Register Free to explore exciting startup investment opportunities.

Scroll to Top